Alberto Serrano-Pozo, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Alzheimer Disease | 48 | 2024 | 8601 | 4.560 |
Why?
|
Plaque, Amyloid | 20 | 2024 | 760 | 3.180 |
Why?
|
Astrocytes | 15 | 2024 | 1341 | 3.090 |
Why?
|
Neurofibrillary Tangles | 10 | 2024 | 457 | 1.650 |
Why?
|
Microglia | 9 | 2024 | 1357 | 1.430 |
Why?
|
Apolipoproteins E | 5 | 2024 | 1443 | 1.380 |
Why?
|
Apolipoprotein E4 | 6 | 2023 | 709 | 1.310 |
Why?
|
Amyloid beta-Peptides | 19 | 2024 | 3839 | 1.230 |
Why?
|
Apolipoprotein E2 | 3 | 2021 | 135 | 1.220 |
Why?
|
Gliosis | 5 | 2024 | 245 | 1.030 |
Why?
|
Lewy Body Disease | 4 | 2024 | 254 | 0.970 |
Why?
|
Frontotemporal Dementia | 2 | 2024 | 246 | 0.770 |
Why?
|
Brain | 27 | 2024 | 27101 | 0.750 |
Why?
|
Receptors, GABA | 2 | 2022 | 313 | 0.740 |
Why?
|
Disease Progression | 5 | 2024 | 13495 | 0.740 |
Why?
|
tau Proteins | 10 | 2024 | 2094 | 0.710 |
Why?
|
Aspartic Acid Endopeptidases | 2 | 2017 | 311 | 0.600 |
Why?
|
Nerve Degeneration | 2 | 2020 | 747 | 0.590 |
Why?
|
PubMed | 1 | 2017 | 129 | 0.530 |
Why?
|
Neurons | 8 | 2024 | 9438 | 0.530 |
Why?
|
Amyloid beta-Protein Precursor | 4 | 2015 | 1111 | 0.510 |
Why?
|
Amyloid Precursor Protein Secretases | 2 | 2017 | 620 | 0.500 |
Why?
|
Neurites | 3 | 2015 | 391 | 0.430 |
Why?
|
Bibliometrics | 1 | 2017 | 352 | 0.420 |
Why?
|
Cognition Disorders | 3 | 2016 | 3979 | 0.390 |
Why?
|
Apolipoprotein E3 | 4 | 2021 | 107 | 0.350 |
Why?
|
Immunohistochemistry | 9 | 2023 | 11069 | 0.350 |
Why?
|
Amyloidosis | 1 | 2016 | 815 | 0.320 |
Why?
|
Temporal Lobe | 2 | 2015 | 1695 | 0.320 |
Why?
|
Autopsy | 4 | 2019 | 1008 | 0.320 |
Why?
|
Genotype | 3 | 2021 | 12978 | 0.310 |
Why?
|
Simvastatin | 1 | 2010 | 346 | 0.290 |
Why?
|
Red Nucleus | 1 | 2007 | 11 | 0.280 |
Why?
|
Aged, 80 and over | 17 | 2024 | 58894 | 0.280 |
Why?
|
Brain Stem Infarctions | 1 | 2007 | 31 | 0.280 |
Why?
|
Glial Fibrillary Acidic Protein | 3 | 2020 | 550 | 0.270 |
Why?
|
Neuroglia | 3 | 2023 | 955 | 0.270 |
Why?
|
Humans | 55 | 2024 | 760617 | 0.250 |
Why?
|
Aged | 24 | 2024 | 169042 | 0.240 |
Why?
|
Vertebral Artery | 1 | 2005 | 184 | 0.240 |
Why?
|
Leprosy | 1 | 2004 | 126 | 0.230 |
Why?
|
Atrophy | 2 | 2024 | 1631 | 0.230 |
Why?
|
Transcription, Genetic | 2 | 2024 | 7583 | 0.230 |
Why?
|
Infarction | 1 | 2005 | 248 | 0.230 |
Why?
|
Supranuclear Palsy, Progressive | 1 | 2024 | 81 | 0.230 |
Why?
|
Synapses | 4 | 2014 | 1755 | 0.220 |
Why?
|
Embolism | 1 | 2007 | 399 | 0.220 |
Why?
|
Polyneuropathies | 1 | 2004 | 137 | 0.220 |
Why?
|
Mitochondria | 4 | 2024 | 3619 | 0.210 |
Why?
|
Longitudinal Studies | 4 | 2021 | 14591 | 0.200 |
Why?
|
Paraffin Embedding | 1 | 2023 | 302 | 0.190 |
Why?
|
Neurodegenerative Diseases | 2 | 2020 | 1085 | 0.190 |
Why?
|
Formaldehyde | 1 | 2023 | 357 | 0.190 |
Why?
|
Biomedical Research | 1 | 2017 | 3426 | 0.190 |
Why?
|
Cholesterol | 1 | 2010 | 2903 | 0.190 |
Why?
|
Tauopathies | 2 | 2015 | 320 | 0.180 |
Why?
|
Cerebral Amyloid Angiopathy | 2 | 2023 | 893 | 0.180 |
Why?
|
Animals | 20 | 2024 | 168201 | 0.180 |
Why?
|
Spinal Diseases | 1 | 2005 | 561 | 0.180 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2021 | 193 | 0.180 |
Why?
|
Hippocampus | 3 | 2021 | 3761 | 0.170 |
Why?
|
Male | 28 | 2024 | 360358 | 0.170 |
Why?
|
Aging | 6 | 2021 | 8699 | 0.170 |
Why?
|
Interneurons | 1 | 2024 | 582 | 0.170 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2004 | 709 | 0.160 |
Why?
|
Spine | 1 | 2005 | 1112 | 0.160 |
Why?
|
Cell Hypoxia | 1 | 2021 | 656 | 0.160 |
Why?
|
Female | 26 | 2024 | 392148 | 0.150 |
Why?
|
Amyloid | 2 | 2015 | 841 | 0.150 |
Why?
|
Gene Expression Profiling | 3 | 2024 | 9417 | 0.150 |
Why?
|
Vaccination | 1 | 2010 | 3370 | 0.150 |
Why?
|
Alleles | 2 | 2021 | 6861 | 0.140 |
Why?
|
Mice | 14 | 2024 | 81368 | 0.140 |
Why?
|
Cohort Studies | 5 | 2021 | 41457 | 0.140 |
Why?
|
Cell Communication | 1 | 2024 | 1654 | 0.130 |
Why?
|
Mice, Transgenic | 6 | 2017 | 9529 | 0.110 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2015 | 304 | 0.110 |
Why?
|
Mental Status Schedule | 1 | 2014 | 315 | 0.110 |
Why?
|
Computational Biology | 2 | 2024 | 3509 | 0.110 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2017 | 619 | 0.110 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2015 | 451 | 0.100 |
Why?
|
Middle Aged | 12 | 2024 | 220584 | 0.100 |
Why?
|
Spinal Cord | 1 | 2021 | 1807 | 0.100 |
Why?
|
Presenilin-1 | 2 | 2015 | 660 | 0.100 |
Why?
|
Coronary Disease | 1 | 2007 | 5912 | 0.100 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2017 | 3800 | 0.100 |
Why?
|
Phenotype | 3 | 2023 | 16571 | 0.100 |
Why?
|
Inflammation Mediators | 1 | 2020 | 1884 | 0.100 |
Why?
|
Cell Count | 2 | 2013 | 1835 | 0.100 |
Why?
|
Tomography | 1 | 2013 | 411 | 0.090 |
Why?
|
Gene Expression | 3 | 2019 | 7568 | 0.090 |
Why?
|
Hydroxycholesterols | 1 | 2010 | 25 | 0.090 |
Why?
|
Neuropsychological Tests | 2 | 2013 | 7050 | 0.090 |
Why?
|
Endothelial Cells | 2 | 2023 | 3548 | 0.090 |
Why?
|
Age of Onset | 2 | 2020 | 3302 | 0.090 |
Why?
|
Transduction, Genetic | 1 | 2013 | 901 | 0.090 |
Why?
|
Protein Folding | 2 | 2014 | 870 | 0.090 |
Why?
|
Voltage-Dependent Anion Channel 1 | 1 | 2010 | 35 | 0.090 |
Why?
|
Phosphorylation | 4 | 2020 | 8311 | 0.090 |
Why?
|
Energy Metabolism | 1 | 2020 | 2878 | 0.080 |
Why?
|
Positron-Emission Tomography | 2 | 2019 | 6483 | 0.080 |
Why?
|
Risk Factors | 4 | 2024 | 74115 | 0.080 |
Why?
|
alpha-Synuclein | 1 | 2015 | 752 | 0.080 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2013 | 1434 | 0.080 |
Why?
|
Dependovirus | 1 | 2013 | 712 | 0.080 |
Why?
|
Dementia | 1 | 2022 | 2680 | 0.070 |
Why?
|
Proteomics | 1 | 2021 | 3836 | 0.070 |
Why?
|
Polyradiculoneuropathy | 1 | 2007 | 65 | 0.070 |
Why?
|
Neocortex | 1 | 2011 | 416 | 0.070 |
Why?
|
Ubiquitin | 1 | 2012 | 839 | 0.070 |
Why?
|
Microscopy, Confocal | 1 | 2013 | 1970 | 0.070 |
Why?
|
Calcium | 1 | 2020 | 5717 | 0.070 |
Why?
|
Mice, Inbred C57BL | 4 | 2020 | 22115 | 0.070 |
Why?
|
Membrane Potential, Mitochondrial | 2 | 2020 | 295 | 0.070 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2012 | 1320 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 3 | 2011 | 36402 | 0.060 |
Why?
|
Guillain-Barre Syndrome | 1 | 2007 | 127 | 0.060 |
Why?
|
Resilience, Psychological | 1 | 2013 | 786 | 0.060 |
Why?
|
Cognition | 3 | 2022 | 6987 | 0.060 |
Why?
|
Vincristine | 1 | 2007 | 1036 | 0.060 |
Why?
|
Sural Nerve | 1 | 2004 | 105 | 0.060 |
Why?
|
Myocardial Infarction | 1 | 2005 | 11459 | 0.060 |
Why?
|
Diagnosis, Differential | 5 | 2015 | 12966 | 0.060 |
Why?
|
RNA, Messenger | 2 | 2017 | 12758 | 0.060 |
Why?
|
Aortography | 1 | 2005 | 421 | 0.060 |
Why?
|
Genetic Vectors | 1 | 2013 | 3392 | 0.060 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2013 | 6016 | 0.050 |
Why?
|
Spain | 1 | 2004 | 487 | 0.050 |
Why?
|
Neural Conduction | 1 | 2004 | 441 | 0.050 |
Why?
|
Putamen | 1 | 2024 | 292 | 0.050 |
Why?
|
Hypercholesterolemia | 1 | 2010 | 1141 | 0.050 |
Why?
|
Solitary Nucleus | 1 | 2023 | 54 | 0.050 |
Why?
|
Anticholesteremic Agents | 1 | 2010 | 967 | 0.050 |
Why?
|
Caudate Nucleus | 1 | 2024 | 390 | 0.050 |
Why?
|
Oxidative Stress | 3 | 2024 | 3113 | 0.050 |
Why?
|
Prevalence | 1 | 2019 | 15689 | 0.050 |
Why?
|
Severity of Illness Index | 2 | 2020 | 15828 | 0.050 |
Why?
|
Entorhinal Cortex | 1 | 2023 | 287 | 0.050 |
Why?
|
Microscopy, Electron | 1 | 2004 | 2561 | 0.050 |
Why?
|
Case-Control Studies | 3 | 2013 | 22148 | 0.050 |
Why?
|
Age Factors | 1 | 2017 | 18381 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 2 | 2019 | 17878 | 0.040 |
Why?
|
Myeloid Cells | 1 | 2024 | 823 | 0.040 |
Why?
|
Ultrasonography | 1 | 2012 | 5964 | 0.040 |
Why?
|
Oxidative Phosphorylation | 1 | 2021 | 495 | 0.040 |
Why?
|
Algorithms | 2 | 2022 | 14018 | 0.040 |
Why?
|
Chest Pain | 1 | 2005 | 1091 | 0.040 |
Why?
|
Green Fluorescent Proteins | 2 | 2015 | 2063 | 0.040 |
Why?
|
Corpus Striatum | 1 | 2024 | 1235 | 0.040 |
Why?
|
Oxidation-Reduction | 1 | 2024 | 2231 | 0.040 |
Why?
|
Cell Proliferation | 1 | 2013 | 10432 | 0.040 |
Why?
|
Inflammation | 2 | 2020 | 10760 | 0.030 |
Why?
|
Disease Models, Animal | 4 | 2024 | 18221 | 0.030 |
Why?
|
Cytosol | 1 | 2020 | 886 | 0.030 |
Why?
|
Genetic Heterogeneity | 1 | 2020 | 733 | 0.030 |
Why?
|
Protein Transport | 2 | 2012 | 1966 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2013 | 15908 | 0.030 |
Why?
|
Antioxidants | 1 | 2024 | 1668 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2014 | 80566 | 0.030 |
Why?
|
Cell Line | 2 | 2021 | 15576 | 0.030 |
Why?
|
Dermoscopy | 1 | 2014 | 66 | 0.030 |
Why?
|
Natural Language Processing | 1 | 2022 | 1163 | 0.030 |
Why?
|
Spinal Cord Injuries | 1 | 2021 | 924 | 0.030 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2013 | 141 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2010 | 9172 | 0.030 |
Why?
|
Biopsy | 1 | 2004 | 6762 | 0.030 |
Why?
|
Matched-Pair Analysis | 1 | 2013 | 284 | 0.030 |
Why?
|
Blotting, Western | 1 | 2020 | 5034 | 0.030 |
Why?
|
Centrifugation, Density Gradient | 1 | 2012 | 299 | 0.030 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2014 | 1738 | 0.020 |
Why?
|
Frontotemporal Lobar Degeneration | 1 | 2012 | 102 | 0.020 |
Why?
|
Multigene Family | 1 | 2015 | 1076 | 0.020 |
Why?
|
Brain Diseases | 1 | 2021 | 1545 | 0.020 |
Why?
|
Protein Binding | 2 | 2015 | 9345 | 0.020 |
Why?
|
Internet | 1 | 2024 | 3090 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 2013 | 1623 | 0.020 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2013 | 695 | 0.020 |
Why?
|
Immunoblotting | 1 | 2014 | 1646 | 0.020 |
Why?
|
Protein Structure, Quaternary | 1 | 2012 | 428 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2020 | 18937 | 0.020 |
Why?
|
Skin | 1 | 2004 | 4473 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2015 | 1490 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2015 | 1608 | 0.020 |
Why?
|
Cerebral Cortex | 2 | 2020 | 5776 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2022 | 20074 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2014 | 2467 | 0.020 |
Why?
|
Presynaptic Terminals | 1 | 2012 | 302 | 0.020 |
Why?
|
Young Adult | 1 | 2017 | 59179 | 0.020 |
Why?
|
Peptide Fragments | 2 | 2012 | 5110 | 0.020 |
Why?
|
Transgenes | 1 | 2013 | 1008 | 0.020 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2020 | 1466 | 0.020 |
Why?
|
Maze Learning | 1 | 2011 | 482 | 0.020 |
Why?
|
Brain Injuries | 1 | 2021 | 2053 | 0.020 |
Why?
|
Adult | 3 | 2024 | 220969 | 0.020 |
Why?
|
Adolescent | 1 | 2017 | 88234 | 0.020 |
Why?
|
Conditioning, Classical | 1 | 2011 | 368 | 0.020 |
Why?
|
Space Perception | 1 | 2011 | 465 | 0.020 |
Why?
|
Paraparesis | 1 | 2007 | 15 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2012 | 1697 | 0.020 |
Why?
|
Ubiquitination | 1 | 2012 | 1006 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2014 | 1528 | 0.020 |
Why?
|
Daunorubicin | 1 | 2007 | 157 | 0.020 |
Why?
|
Paresthesia | 1 | 2007 | 162 | 0.020 |
Why?
|
Urination Disorders | 1 | 2007 | 238 | 0.020 |
Why?
|
Reference Values | 1 | 2013 | 4919 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2012 | 2639 | 0.020 |
Why?
|
Cytarabine | 1 | 2007 | 697 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2022 | 4803 | 0.020 |
Why?
|
Protein Conformation | 1 | 2012 | 3965 | 0.010 |
Why?
|
Transfection | 1 | 2012 | 5766 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2024 | 12661 | 0.010 |
Why?
|
Medicare | 1 | 2022 | 6765 | 0.010 |
Why?
|
Lipid Metabolism | 1 | 2012 | 1896 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2012 | 6224 | 0.010 |
Why?
|
Psychometrics | 1 | 2013 | 3060 | 0.010 |
Why?
|
Erectile Dysfunction | 1 | 2007 | 444 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2012 | 4269 | 0.010 |
Why?
|
Qualitative Research | 1 | 2013 | 3016 | 0.010 |
Why?
|
Prednisone | 1 | 2007 | 1562 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2007 | 1835 | 0.010 |
Why?
|
Fear | 1 | 2011 | 1477 | 0.010 |
Why?
|
Remission Induction | 1 | 2007 | 2391 | 0.010 |
Why?
|
Memory | 1 | 2011 | 2192 | 0.010 |
Why?
|
Methotrexate | 1 | 2007 | 1716 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2013 | 4058 | 0.010 |
Why?
|
Action Potentials | 1 | 2007 | 1825 | 0.010 |
Why?
|
Dexamethasone | 1 | 2007 | 1947 | 0.010 |
Why?
|
Sex Factors | 1 | 2013 | 10548 | 0.010 |
Why?
|
Hydrocortisone | 1 | 2007 | 1819 | 0.010 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2007 | 1551 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2013 | 14389 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2015 | 11874 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2013 | 8998 | 0.010 |
Why?
|
United States | 1 | 2022 | 72272 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 11736 | 0.000 |
Why?
|